For localized information and support, would you like to switch to your country-specific website for {0}?
Tab1
Vision
Unified vision: Advancing together for a healthier future
We believe the future of diagnostics is collaborative.
From academic partnerships and government alliances to cross-industry research and our global network of laboratories, we work together to address the world’s most pressing health challenges, at the single-patient level and for the broadest of populations.
To be ahead of care, we must always be ahead of what’s next—ahead of new dimensions, ahead of next-generation technologies, ahead of global pandemics, ahead of oncology diagnostics, and ahead of countless other frontiers yet to be defined.
To truly bring all communities the access and equitable outcomes they deserve, and to address the growing pressures of healthcare systems and the shifting profile of global disease burden, a meaningful transformation in healthcare is essential.
We believe we can accomplish this through our scientific boldness, extensive internal and external networks, and connected capabilities across diagnostics, pharmaceuticals, and data-driven insights. Together, we aim to deliver more tailored, effective, and accessible care for all.
By bringing the strengths of our Diagnostics and Pharma divisions together, and leveraging AI, digital ecosystems, and advanced analytics, this unified vision will come to life: for more integrated care, more equitable outcomes, and a more sustainable future.
Viability
Undeniable viability: Innovation that stands the test of time
When lives depend on accuracy, trust matters most.
Our solutions are built on rigorous validation and decades of scientific leadership. We invest more in research and development than any other diagnostics company, ensuring every system, assay, and digital platform delivers reliable results that meet clinical and patient needs.
At Roche Diagnostics, being ahead of care isn’t just a promise; it is our legacy of innovation in action. For over a century, we’ve been the quiet force pushing boundaries, combining scientific breakthroughs with practical laboratory solutions that transform healthcare.
In 2023 alone, we helped treat more than 22 million people with Roche medicines and conducted over 30 billion diagnostic tests worldwide. Furthermore, 90 Roche Diagnostics products are included on the World Health Organization’s List of Essential Medicines and Tests - a testament to our enduring commitment to improving lives through reliable, proven innovation.
From next-generation sequencing and mass spectrometry to AI-powered diagnostic algorithms and digital pathology, each advancement is designed to simplify workflows, enhance precision, and strengthen confidence in clinical decisions.
Visability
Inspiring visibility: Bringing unseen science to light
Behind every test result lies years of discovery, testing, and refinement, most of which happens out of view. Yet these unseen innovations shape the future of patient care.
Ahead of clinical decisions, biomarkers bring answers, and clinicians want confidence.
We deliver precision diagnostics that often provide personalised solutions: from predictive cancer treatment insights to managing diabetes, to safeguarding pregnancy journeys, and beyond.
Everything we do is also grounded in our commitment to sustainability, protecting our planet’s resources now and for future generations. Solving for tomorrow means meeting ambitious environmental goals while advancing our social and economic responsibilities, ensuring that every innovation delivers long-term value for people and the planet.
By bringing forward only the most meaningful ideas, those with proven medical, economic, and social value, we help healthcare systems do more with less, expanding access and ensuring sustainable progress for generations to come.
Building on our legacy of innovation
Healthcare doesn’t start with treatment; it starts with the insights behind a patient’s medical history, symptoms, presentation, and story. Before a disease can be stopped, cured, or prevented, clinicians need definitive, clinical information they can trust, sometimes even before symptoms appear.
That’s where we come in. At Roche Diagnostics, we’re ahead of care because we empower healthcare providers to act earlier, faster, and with confidence. We help uncover hidden disease, connect questions with action, and drive more equitable outcomes for a sustainable future of care.
Diagnostics come first, so care can move forward faster and help change lives for the better.
13 billion CHF invested in R&D in 2024
>100,000 dedicated employees taking on the most complex challenges in healthcare
>125 years driving innovation from ideas to diagnostic solutions
Transforming diagnostics through scientific excellence, collaboration, and trust.
For more than a century, Roche Diagnostics has quietly powered healthcare forward, pairing scientific breakthroughs with practical solutions that help laboratories, clinicians, and patients make more confident, next-step decisions.
We are building on our established legacy and continuing to find partnerships with healthcare pioneers and customers worldwide to solve problems that bring medical, economic, and social value to providers and patients alike. Our focus is on expanding access to quality care and creating a more sustainable future that provides equitable outcomes, a goal that depends on a more decentralized approach and concentration on disease areas with high unmet need.
Our innovation is guided by a shared and unified diagnostic vision, one that looks ahead collaboratively, through partnership and proven scientific expertise, anchored in existing and still to be discovered technologies.
It’s defined by unquestionable dedication to making systems viable, with reliable, accurate, and validated solutions that simply work. It is inspired by the potential power of investigative ideas, bringing only the worthiest ones to the front and center, making them available and visible. We have a history of investing in a multitude of yet-to-be-proven concepts that become future-ready, essential diagnostic tools, promising even further integration and connection in both physical and digital realms.
Together, these pillars for vision, visibility, and viability define what it means to be ahead of care.
Vision
Unified vision: Advancing together for a healthier future
We believe the future of diagnostics is collaborative.
From academic partnerships and government alliances to cross-industry research and our global network of laboratories, we work together to address the world’s most pressing health challenges, at the single-patient level and for the broadest of populations.
To be ahead of care, we must always be ahead of what’s next—ahead of new dimensions, ahead of next-generation technologies, ahead of global pandemics, ahead of oncology diagnostics, and ahead of countless other frontiers yet to be defined.
To truly bring all communities the access and equitable outcomes they deserve, and to address the growing pressures of healthcare systems and the shifting profile of global disease burden, a meaningful transformation in healthcare is essential.
We believe we can accomplish this through our scientific boldness, extensive internal and external networks, and connected capabilities across diagnostics, pharmaceuticals, and data-driven insights. Together, we aim to deliver more tailored, effective, and accessible care for all.
By bringing the strengths of our Diagnostics and Pharma divisions together, and leveraging AI, digital ecosystems, and advanced analytics, this unified vision will come to life: for more integrated care, more equitable outcomes, and a more sustainable future.
Viability
Undeniable viability: Innovation that stands the test of time
When lives depend on accuracy, trust matters most.
Our solutions are built on rigorous validation and decades of scientific leadership. We invest more in research and development than any other diagnostics company, ensuring every system, assay, and digital platform delivers reliable results that meet clinical and patient needs.
At Roche Diagnostics, being ahead of care isn’t just a promise; it is our legacy of innovation in action. For over a century, we’ve been the quiet force pushing boundaries, combining scientific breakthroughs with practical laboratory solutions that transform healthcare.
In 2023 alone, we helped treat more than 22 million people with Roche medicines and conducted over 30 billion diagnostic tests worldwide. Furthermore, 90 Roche Diagnostics products are included on the World Health Organization’s List of Essential Medicines and Tests - a testament to our enduring commitment to improving lives through reliable, proven innovation.
From next-generation sequencing and mass spectrometry to AI-powered diagnostic algorithms and digital pathology, each advancement is designed to simplify workflows, enhance precision, and strengthen confidence in clinical decisions.
Visability
Inspiring visibility: Bringing unseen science to light
Behind every test result lies years of discovery, testing, and refinement, most of which happens out of view. Yet these unseen innovations shape the future of patient care.
Ahead of clinical decisions, biomarkers bring answers, and clinicians want confidence.
We deliver precision diagnostics that often provide personalised solutions: from predictive cancer treatment insights to managing diabetes, to safeguarding pregnancy journeys, and beyond.
Everything we do is also grounded in our commitment to sustainability, protecting our planet’s resources now and for future generations. Solving for tomorrow means meeting ambitious environmental goals while advancing our social and economic responsibilities, ensuring that every innovation delivers long-term value for people and the planet.
By bringing forward only the most meaningful ideas, those with proven medical, economic, and social value, we help healthcare systems do more with less, expanding access and ensuring sustainable progress for generations to come.
At Roche Diagnostics, innovation is more than invention; it is intention.
Every solution we create reflects our commitment to scientific integrity, global collaboration, and a healthier, more sustainable world.
We are building our legacy—one discovery, one partnership, and one patient at a time.
Innovation stories
Multiplex testing: Solving for efficiency and efficacy
Multiplex testing detects multiple targets simultaneously, enabling diagnostic labs to operate more efficiently and sustainably.
Revolutionizing the clinical lab with mass spectrometry
Mass spectrometry offers better sensitivity and specificity for identifying molecular structure and chemical composition compared to traditional methods.
Sequencing by expansion: A novel approach to next generation sequencing
Sequencing by expansion (SBX) is a new next generation sequencing technology that is proving to be a critical tool for precision medicine and diagnostics.
How digital technologies can help achieve operational excellence in the lab
Achieving operational excellence in healthcare is not easy, but embracing digital technologies to improve lab operations is the first step in the journey..
...
